Page de couverture de Degenerate

Degenerate

Aperçu
Essayer pour 0,00 $
Choisissez 1 livre audio par mois dans notre incomparable catalogue.
Écoutez à volonté des milliers de livres audio, de livres originaux et de balados.
L'abonnement Premium Plus se renouvelle automatiquement au tarif de 14,95 $/mois + taxes applicables après 30 jours. Annulation possible à tout moment.

Degenerate

Auteur(s): Matt Casamassina
Narrateur(s): Phillip Nathaniel Freeman
Essayer pour 0,00 $

14,95$ par mois après 30 jours. Annulable en tout temps.

Acheter pour 31,27 $

Acheter pour 31,27 $

À propos de cet audio

The latest novel from Matt Casamassina, author of Sophistication, which Kirkus Reviews called "Ambitious. Well-paced. Riveting. [Casamassina] occasionally reaches moments of lyricism.”

Mason Kowalski, a twenty-four year-old copywriter for a San Mateo startup, is on the verge of a nervous breakdown when he inexplicably suffers widespread vision loss in one eye. The doctors say it’s macular degeneration triggered by overwhelming stress, but he wonders if it’s something more, especially when the shadows in his peripheral vision begin to take shape and whisper wonderful and horrible things to him. Is it madness or destiny? The answer could destroy everything and everyone he holds dear.

Journey into the absurd beating heart of Silicon Valley as Mason and his lovable friends try to stop a demented serial killer from murdering more children. Degenerate mashes horror and sci-fi into a twisted, dark, violent and funny pulp drowned in tentacled nightmares. Featuring infamous hijacker DB Cooper and more twists than you can imagine, the genre-breaking story is designed for fans of Stephen King, Blake Crouch, Peter Clines, Keith Rosson, Chuck Wendig and John Scalzi.

©2025 Matt Casamassina (P)2025 Matt Casamassina
Post-apocalyptique Science-fiction Drôle Effrayant

Ce que les critiques en disent

“As ambitious as it is unpredictable.” - Kirkus Reviews

“A resolutely unclassifiable epic from Casamassina that blends genres into the wildest of elixirs.” - Publishers Weekly

Pas encore de commentaire